Table of Content

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY RESEARCH 19
2.1.1.1 Key data from secondary sources 19
2.1.2 PRIMARY RESEARCH 20
2.1.2.1 Key data from primary sources 20
2.1.2.2 Breakdown of primaries 21
2.2 MARKET SIZE ESTIMATION 21
2.3 DATA TRIANGULATION APPROACH 23
2.4 MARKET SHARE ANALYSIS 24
2.5 ASSUMPTIONS FOR THE STUDY 24

3 EXECUTIVE SUMMARY 25

4 PREMIUM INSIGHTS 28
4.1 ELECTRONIC DRUG DELIVERY SYSTEMS: MARKET OVERVIEW 28
4.2 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2018 29
4.3 GEOGRAPHICAL SNAPSHOT OF THE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 30

5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
5.2.1 DRIVERS 32
5.2.1.1 Growing prevalence of target diseases 32
5.2.1.2 Favorable reimbursement scenario in major markets 32
5.2.1.3 Advancements in technologies and designs 33
5.2.2 RESTRAINTS 33
5.2.2.1 Preference for alternative drug delivery modes and the possibility of errors 33
5.2.3 OPPORTUNITIES 34
5.2.3.1 Increasing demand for biologics and mAbs 34
5.2.3.2 Growth opportunities in emerging markets 35
5.2.4 CHALLENGES 35
5.2.4.1 Unfavorable reimbursement structure in developing countries 35

6 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 36
6.1 INTRODUCTION 37
6.1.1 ELECTRONIC WEARABLE INFUSION PUMPS 38
6.1.1.1 Electronic wearable infusion pumps dominate the electronic drug delivery systems market 38
6.1.2 ELECTRONIC AUTOINJECTORS 42
6.1.2.1 Electronic autoinjectors are likely to register negative growth during the forecast period due to the continuous influx of generic versions of conventional autoinjectors in the market 42
6.1.3 ELECTRONIC INJECTION PENS 44
6.1.3.1 Growing focus of pharmaceutical companies on developing electronic/connected injection pens will drive market growth 44
6.1.4 ELECTRONIC INHALERS 47
6.1.4.1 Electronic inhalers are developed to improve medication adherence in asthma & COPD management 47

7 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION 48
7.1 INTRODUCTION 49
7.2 DIABETES 50
7.2.1 DIABETES ACCOUNTED FOR THE LARGEST SEGMENT OF THE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 50
7.3 MULTIPLE SCLEROSIS 52
7.3.1 LAUNCH OF GENERIC VERSIONS OF CONVENTIONAL INJECTABLES WILL STIFLE MARKET GROWTH 52
7.4 CARDIOVASCULAR DISEASE 54
7.4.1 DEVELOPMENT OF INNOVATIVE ELECTRONIC DRUG DELIVERY SYSTEMS FOR CVD TREATMENT WILL DRIVE MARKET GROWTH 54
7.5 ASTHMA & COPD 57
7.5.1 DEVELOPMENT OF SMART INHALERS AND DIGITAL SENSORS IS LIKELY TO IMPROVE MEDICATION ADHERENCE IN ASTHMA & COPD PATIENTS 57
7.6 OTHER INDICATIONS 58

8 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY REGION 61
8.1 INTRODUCTION 62
8.2 NORTH AMERICA 64
8.2.1 US 66
8.2.1.1 The US has a favorable reimbursement scenario for electronic drug delivery devices, which is a key factor driving the market for electronic drug delivery systems 66
?
8.2.2 CANADA 68
8.2.2.1 Growing presence of device manufacturers in the country is expected to propel market growth 68
8.3 EUROPE 69
8.3.1 GERMANY 72
8.3.1.1 Germany is the largest market for electronic drug delivery systems in Europe 72
8.3.2 UK 73
8.3.2.1 High burden of target diseases to support market growth 73
8.3.3 FRANCE 74
8.3.3.1 High prevalence of diabetes in the country to propel market growth 74
8.3.4 REST OF EUROPE 75
8.4 ASIA PACIFIC 76
8.4.1 JAPAN 79
8.4.1.1 Large geriatric population and the high prevalence of CVD to support market growth 79
8.4.2 CHINA 80
8.4.2.1 Growing focus of major players on biologics development to drive market growth 80
8.4.3 INDIA 81
8.4.3.1 Lack of reimbursement and guidelines on electronic drug delivery systems could limit market growth 81
8.4.4 ROAPAC 82
8.5 REST OF THE WORLD 83
8.5.1 LATIN AMERICA 85
8.5.1.1 High incidence of chronic diseases to drive the demand for electronic drug delivery systems 85
8.5.2 MIDDLE EAST & AFRICA 86
8.5.2.1 Favorable reforms in South Africa to support market growth 86

9 COMPETITIVE LANDSCAPE 88
9.1 OVERVIEW 88
9.2 MARKET SHARE ANALYSIS 88
9.3 KEY PLAYER ANALYSIS 88
9.3.1 MERCK GROUP 88
9.3.2 MEDTRONIC PLC 89
9.4 COMPETITIVE SCENARIO 89
9.4.1 PRODUCT LAUNCHES 89
9.4.2 EXPANSIONS 89
9.4.3 AGREEMENTS & COLLABORATIONS 90
9.5 COMPETITIVE LEADERSHIP MAPPING (2018) 91
9.5.1 VISIONARY LEADERS 91
9.5.2 INNOVATORS 91
?
9.5.3 DYNAMIC DIFFERENTIATORS 91
9.5.4 EMERGING COMPANIES 91

10 COMPANY PROFILES 93
(Business overview, Products offered, Recent Developments)*
10.1 MERCK GROUP 93
10.2 MEDTRONIC PLC 95
10.3 UNITED THERAPEUTICS CORPORATION 97
10.4 INSULET CORPORATION 99
10.5 BAYER AG 101
10.6 NOVO NORDISK 103
10.7 COMPANION MEDICAL 105
10.8 TANDEM DIABETES CARE, INC. 106
10.9 F.HOFFMANN-LA ROCHE, LTD. 108
10.10 AMGEN, INC. 110
10.11 ASTRAZENECA PLC 112
10.12 FINDAIR SP. Z O. O. 114
10.13 VICENTRA B.V. 115
10.14 CAN? SPA 116
10.15 DEBIOTECH S.A. 117
*Details on Business overview, Products offered, Recent Developments might not be captured in case of unlisted companies.

11 APPENDIX 118
11.1 DISCUSSION GUIDE 118
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 121
11.3 RELATED REPORTS 123
11.4 AUTHOR DETAILS 124



List of Figures



FIGURE 1 RESEARCH DESIGN 18
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE DESIGNATION, AND REGION 21
FIGURE 3 BOTTOM-UP APPROACH 21
FIGURE 4 TOP-DOWN APPROACH 22
FIGURE 5 DATA TRIANGULATION METHODOLOGY 23
FIGURE 6 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SHARE, BY TYPE, 2018 25
FIGURE 7 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SHARE, BY INDICATION, 2018 26
FIGURE 8 GEOGRAPHIC SNAPSHOT: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, 2018 27
FIGURE 9 GROWING PREVALENCE OF CHRONIC DISEASES IS LIKELY TO DRIVE THE MARKET FOR ELECTRONIC DRUG DELIVERY SYSTEMS 28
FIGURE 10 ELECTRONIC WEARABLE INFUSION PUMPS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN ELECTRONIC DRUG DELIVERY SYSTEMS
MARKET IN 2018 29
FIGURE 11 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 30
FIGURE 12 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 31
FIGURE 13 ELECTRONIC WEARABLE INFUSION PUMPS TO DOMINATE THE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET IN THE FORECAST PERIOD 37
FIGURE 14 DIABETES INDICATIONS TO REGISTER THE HIGHEST CAGR OF THE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET DURING THE FORECAST PERIOD 49
FIGURE 15 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY REGION, 2019 VS. 2024 62
FIGURE 16 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SNAPSHOT 65
FIGURE 17 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SNAPSHOT 70
FIGURE 18 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SNAPSHOT 77
FIGURE 19 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET SNAPSHOT 84
FIGURE 20 MARKET SHARE ANALYSIS, BY KEY PLAYER (2018) 88
FIGURE 21 COMPETITIVE LEADERSHIP MAPPING: ELECTRONIC DRUG DELIVERY
SYSTEMS MARKET 92
FIGURE 22 MERCK GROUP: COMPANY SNAPSHOT 93
FIGURE 23 MEDTRONIC PLC: COMPANY SNAPSHOT 95
FIGURE 24 UNITED THERAPEUTICS CORPORATION: COMPANY SNAPSHOT 97
FIGURE 25 INSULET CORPORATION: COMPANY SNAPSHOT 99
FIGURE 26 BAYER AG: COMPANY SNAPSHOT 101
FIGURE 27 NOVO NORDISK: COMPANY SNAPSHOT 103
FIGURE 28 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT 106
FIGURE 29 F.HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 108
FIGURE 30 AMGEN, INC.: COMPANY SNAPSHOT 110
FIGURE 31 ASTRAZENECA PLC: COMPANY SNAPSHOT 112

 

List of Tables



TABLE 1 COMMERCIALLY AVAILABLE BIOLOGICS AS POTENTIAL APPLICATIONS FOR ELECTRONIC DRUG DELIVERY SYSTEMS IN THE COMING YEARS 34
TABLE 2 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 37
TABLE 3 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY PRODUCT 2017–2024 (USD MILLION) 38
TABLE 4 COMPARATIVE TABLE OF COMMERCIALLY AVAILABLE INSULIN PUMPS 39
TABLE 5 ELECTRONIC WEARABLE INFUSION PUMPS MARKET, BY REGION 2017–2024 (USD MILLION) 41
TABLE 6 NORTH AMERICA: ELECTRONIC WEARABLE INFUSION PUMPS MARKET BY COUNTRY, 2017–2024 (USD MILLION) 41
TABLE 7 EUROPE: ELECTRONIC WEARABLE INFUSION PUMPS MARKET BY COUNTRY, 2017–2024 (USD MILLION) 41
TABLE 8 ASIA PACIFIC: ELECTRONIC WEARABLE INFUSION PUMPS MARKET BY COUNTRY, 2017–2024 (USD MILLION) 42
TABLE 9 ROW: ELECTRONIC WEARABLE INFUSION PUMPS MARKET, BY REGION 2017–2024 (USD MILLION) 42
TABLE 10 ELECTRONIC AUTOINJECTORS MARKET, BY REGION, 2017–2024 (USD MILLION) 43
TABLE 11 NORTH AMERICA: ELECTRONIC AUTOINJECTORS MARKET, BY COUNTRY 2017–2024 (USD MILLION) 43
TABLE 12 EUROPE: ELECTRONIC AUTOINJECTORS MARKET, BY COUNTRY 2017–2024 (USD MILLION) 43
TABLE 13 ASIA PACIFIC: ELECTRONIC AUTOINJECTORS MARKET, BY COUNTRY 2017–2024 (USD MILLION) 44
TABLE 14 ROW: ELECTRONIC AUTOINJECTORS MARKET, BY REGION 2017–2024 (USD MILLION) 44
TABLE 15 ELECTRONIC INJECTION PENS MARKET, BY REGION, 2017–2024 (USD MILLION) 45
TABLE 16 NORTH AMERICA: ELECTRONIC INJECTION PENS MARKET BY COUNTRY, 2017–2024 (USD MILLION) 45
TABLE 17 EUROPE: ELECTRONIC INJECTION PENS MARKET, BY COUNTRY 2017–2024 (USD MILLION) 45
TABLE 18 ASIA PACIFIC: ELECTRONIC INJECTION PENS MARKET, BY COUNTRY 2017–2024 (USD MILLION) 46
TABLE 19 ROW: ELECTRONIC INJECTION PENS MARKET, BY REGION 2017–2024 (USD MILLION) 46
TABLE 20 ELECTRONIC INHALERS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 47
TABLE 21 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION 2017–2024 (USD MILLION) 49
TABLE 22 TOP FIVE COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS
(20–79 YEARS), 2017 VS. 2045 50
TABLE 23 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR DIABETES BY REGION, 2017–2024 (USD MILLION) 51
TABLE 24 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR DIABETES, BY COUNTRY, 2017–2024 (USD MILLION) 51
TABLE 25 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR DIABETES BY COUNTRY, 2017–2024 (USD MILLION) 51
TABLE 26 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR DIABETES BY COUNTRY, 2017–2024 (USD MILLION) 52
TABLE 27 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR DIABETES BY REGION, 2017–2024 (USD MILLION) 52
TABLE 28 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR MULTIPLE SCLEROSIS BY REGION, 2017–2024 (USD MILLION) 53
TABLE 29 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2017–2024 (USD MILLION) 53
TABLE 30 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2017–2024 (USD MILLION) 53
TABLE 31 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2017–2024 (USD MILLION) 54
TABLE 32 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR MULTIPLE SCLEROSIS, BY REGION, 2017–2024 (USD MILLION) 54
TABLE 33 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2017–2024 (USD MILLION) 55
TABLE 34 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 35 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2017–2024 (USD MILLION) 56
TABLE 36 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2017–2024 (USD MILLION) 56
TABLE 37 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2017–2024 (USD MILLION) 56
TABLE 38 PREVALENCE OF COPD & ASTHMA IN 2010 AND 2016 (MILLION) 57
TABLE 39 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR ASTHMA & COPD BY COUNTRY, 2017–2024 (USD MILLION) 58
TABLE 40 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR OTHER INDICATIONS BY REGION, 2017–2024 (USD MILLION) 59
TABLE 41 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 59
TABLE 42 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 59
TABLE 43 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 44 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET FOR OTHER INDICATIONS, BY REGION, 2017–2024 (USD MILLION) 60
TABLE 45 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY REGION 2017–2024 (USD MILLION) 63
TABLE 46 ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY 2017–2024 (USD MILLION) 63
TABLE 47 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY COUNTRY, 2017–2024 (USD MILLION) 65
TABLE 48 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY TYPE, 2017–2024 (USD MILLION) 66
TABLE 49 NORTH AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY INDICATION, 2017–2024 (USD MILLION) 66
TABLE 50 US: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 67
TABLE 51 US: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION 2017–2024 (USD MILLION) 67
TABLE 52 CANADA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY TYPE, 2017–2024 (USD MILLION) 68
TABLE 53 CANADA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION) 68
TABLE 54 EUROPE: RECENT DEVELOPMENTS IN THE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, 2017–2018 69
TABLE 55 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY 2017–2024 (USD MILLION) 71
TABLE 56 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 71
TABLE 57 EUROPE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION) 71
TABLE 58 GERMANY: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 72
TABLE 59 GERMANY: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION) 72
TABLE 60 UK: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 73
TABLE 61 UK: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION 2017–2024 (USD MILLION) 74
TABLE 62 FRANCE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 74
TABLE 63 FRANCE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION) 75
TABLE 64 ROE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 76
TABLE 65 ROE: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION 2017–2024 (USD MILLION) 76
TABLE 66 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 78
TABLE 67 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 78
TABLE 68 ASIA PACIFIC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION) 78
TABLE 69 JAPAN: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 79
TABLE 70 JAPAN: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION 2017–2024 (USD MILLION) 80
TABLE 71 CHINA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 80
TABLE 72 CHINA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION 2017–2024 (USD MILLION) 81
TABLE 73 INDIA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 81
TABLE 74 INDIA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION 2017–2024 (USD MILLION) 82
TABLE 75 ROAPAC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 83
TABLE 76 ROAPAC: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION) 83
TABLE 77 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY REGION 2017–2024 (USD MILLION) 84
TABLE 78 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY TYPE 2017–2024 (USD MILLION) 85
TABLE 79 ROW: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, BY INDICATION 2017–2024 (USD MILLION) 85
TABLE 80 LATIN AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY TYPE, 2017–2024 (USD MILLION) 86
TABLE 81 LATIN AMERICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY INDICATION, 2017–2024 (USD MILLION) 86
TABLE 82 MIDDLE EAST & AFRICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY TYPE, 2017–2024 (USD MILLION) 87
TABLE 83 MIDDLE EAST & AFRICA: ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY INDICATION, 2017–2024 (USD MILLION) 87
TABLE 84 PRODUCT LAUNCHES 89
TABLE 85 EXPANSIONS 89
TABLE 86 AGREEMENTS & COLLABORATIONS 90
TABLE 87 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF EUR TO USD) 102